Monroe Capital Earnings Call Transcripts
Fiscal Year 2026
-
The meeting was adjourned due to lack of quorum and rescheduled for July 28, 2026. Proxies remain valid, and shareholders can submit or change votes before the new date. Attendees were thanked for their understanding.
-
Shareholders approved both the asset sale and merger proposals, each receiving over 53% of outstanding shares in favor. Quorum was established, and voting results will be reported to the SEC within four business days.
Fiscal Year 2025
-
The meeting covered director elections and approval to sell shares below net asset value, with both proposals passing by majority vote. No shareholder questions were raised, and all governance procedures were followed.
-
Q1 2025 saw lower investment income and portfolio contraction, but stable asset quality and proactive exits supported a 14.3% dividend yield, aided by spillover income. Leverage improved, and the portfolio remains defensively positioned amid market volatility.
Fiscal Year 2024
-
Adjusted Net Investment Income covered the dividend, with an 11.4% annualized yield, despite a 3.6% NAV decline due to unrealized losses. Management expects a more active deal environment in 2025 and is focused on portfolio growth and resolving non-accruals.
-
Adjusted net investment income covered the dividend for the 18th straight quarter, with a stable NAV and improved net loss. The Wendel Group partnership brings $1 billion in new capital, supporting future growth and diversification.
-
Adjusted net investment income increased and covered the dividend for the 17th straight quarter, with a stable 14% yield. NAV declined slightly due to unrealized losses, but portfolio quality and yields remain strong amid a competitive lending environment.
-
The meeting covered director elections, share sale authorization, and governance procedures. All proposals passed, including the election of a Class III director and approval to sell shares below net asset value. No shareholder questions were raised.